Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

The guideline recommends personalized treatment for alopecia areata, including new oral medications and psychological support.

Many are open to telemedicine for hair loss if combined with in-person visits and better technology.

New medications could improve treatment for severe alopecia areata in Australia.

FemmeBalance supplement significantly improved PMS symptoms in women.

International guidelines for treating alopecia areata vary, focusing on different treatment options and related health issues.

Liposomal delivery systems improve drug absorption through the skin, offering potential for better treatments.

Low-dose oral minoxidil might help with hair loss during chemotherapy, but more research is needed.

JAK inhibitors show promise for treating alopecia areata but have serious side effects.

Specific miRNA profiles can help diagnose and treat alopecia areata.

Women with PCOS have a higher risk of heart disease.

Transgender men need personalized cancer care and continued testosterone therapy for well-being.

Hair specialists vary in testing for alopecia areata, highlighting the need for standard guidelines.

Alopecia areata patients have higher risks of infections, lymphoma, heart issues, and death.

Unique microRNA patterns can help diagnose and treat severe alopecia areata.

Advanced techniques and technologies can improve burn wound healing, but more research is needed.

Human umbilical cord stem cell vesicles may help treat aging and related diseases.

Testosterone with finasteride improved muscle and bone health in men with spinal cord injury.

Adding vitamin B12 to food like salt can effectively improve vitamin levels in rural areas.

VLDL could be an early warning sign for male pattern baldness.

Long COVID causes a wide range of long-lasting symptoms that change over time and are hard to diagnose and treat.

Digital gangrene can be an unusual first sign of late-onset lupus.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

A mix of Polygonatum sibiricum and Nelumbinis semen may ease menopause symptoms with fewer side effects.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

Sex hormones affect hair growth and loss, and treatments for related hair diseases include various medications, hair transplantation, and light therapy.

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.